Skip to main content
. 2006 Oct 17;3(10):e400. doi: 10.1371/journal.pmed.0030400

Figure 1. Mortality in Cardiovascular Health Study Participants According to Glycemic Status and the Type of Antihyperglycemic Treatment.

Figure 1

The cohort consisted of 5,372 participants without DM, 322 with DM treated with OHGAs, and 194 with DM treated with insulin with or without OHGAs followed from 1989 to 2001.

(A) Total mortality of the cohort is plotted with regard to diabetes status.

(B) Mortality due to CVD.

(C) Mortality due to CHD.

(D) Mortality due to noncardiovascular causes.

(E) Mortality due to sepsis, metabolic derangement, and renal disease.